PTC Therapeutics CEO Stuart Peltz's 2020 pay jumps 36% to $11M
PTC Therapeutics reports 2020 executive compensation
By ExecPay News
Published: April 29, 2021
PTC Therapeutics reported fiscal year 2020 executive compensation information on April 29, 2021.
In 2020, six executives at PTC Therapeutics received on average a compensation package of $5.1M, a 35% increase compared to previous year.
Average pay of disclosed executives at PTC Therapeutics
Stuart W. Peltz, Chief Executive Officer, received $11M in total, which increased by 36% compared to 2019. 68% of Peltz's compensation, or $7.2M, was in option awards. Peltz also received $835K in non-equity incentive plan, $742K in salary, $1.7M in stock awards, as well as $124K in other compensation.
Marcio Souza, Chief Operating Officer, received a compensation package of $4.4M, which increased by 19% compared to previous year. 81% of the compensation package, or $3.6M, was in option awards.
Eric Pauwels, Chief Business Officer, earned $4.4M in 2020.
Neil Almstead, Chief Technical Operations Officer, received $3.9M in 2020, which increases by 55% compared to 2019.
Emily Hill, Chief Financial Officer, earned $3.7M in 2020, a 57% increase compared to previous year.
Mark E. Boulding, Chief Legal Officer, received $3.5M in 2020, which increases by 41% compared to 2019.
Related executives
Stuart Peltz
PTC Therapeutics
Chief Executive Officer
Emily Hill
PTC Therapeutics
Chief Financial Officer
Neil Almstead
PTC Therapeutics
Chief Technical Operations Officer
Mark Boulding
PTC Therapeutics
Chief Legal Officer
Eric Pauwels
PTC Therapeutics
Chief Business Officer
Marcio Souza
PTC Therapeutics
Chief Operating Officer
You may also like
Source: SEC filing on April 29, 2021.